Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Mechanisms of Development|September 3, 1999
An octamer-binding site is crucial for the activity of an enhancer active at the embryonic met-/mesencephalic junctionD Mihailescu, P Küry, D MonardRestorative Neurology and Neuroscience|June 26, 2002
Gene expression profiling and molecular aspects in peripheral nerve regenerationF Bosse, P Küry, H W MüllerDevelopment (Cambridge, England)|March 1, 1997
Protease nexin-1 is expressed at the mouse met-/mesencephalic junction and FGF signaling regulates its promoter activity in primary met-/mesencephalic cellsP Küry, N Schaeren-Wiemers, D MonardCurrent Opinion in Neurology|September 20, 2001
Molecular mechanisms of cellular interactions in peripheral nerve regenerationP Küry, G Stoll, H W MüllerMechanisms of Development|December 1, 1996
A Krox binding site regulates protease nexin-1 promoter activity in embryonic heart, cartilage and parts of the nervous systemH Ernø, P Küry, F M Botteri, et al.Der Nervenarzt|July 1, 2015
[New therapeutic strategies for remyelination in multiple sclerosis]D Kremer, H-P Hartung, M Stangel, et al.Molecular Microbiology|January 1, 1997
Characterization of a mitogen-activated protein (MAP) kinase from Plasmodium falciparumR Graeser, P Küry, R M Franklin, et al.Molecular and Cellular Neurosciences|February 16, 2000
Eph receptors and ephrin expression in cranial motor neurons and the branchial arches of the chick embryoP Küry, N Gale, R Connor, et al.Molecular and Cellular Neurosciences|January 1, 1996
Excitotoxic brain lesion modifies binding to a USF binding site acting as a negative regulatory element in the Protease nexin-1 promoterH Ernø, P Küry, C Nitsch, et al.Der Nervenarzt|September 16, 2010
[Oral fingolimod in multiple sclerosis: therapeutic modulation of the sphingosine-1-phosphate system]O Aktas, J Ingwersen, B Kieseier, et al.Pageof 2